Vistagen Appoints Cindy Anderson as Chief Financial Officer

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $VTGN #mentalhealth–Vistagen (NASDAQ: VTGN) a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, today announced the appointment of Cindy Anderson as Chief Financial Officer (CFO), effective August 21, 2023. Ms. Anderson will succeed Jerrold Dotson, whose planned retirement was announced in July of this year. “We are delighted to welc

Recent Articles